CNR insider sale: 3,800 shares reported
John Rothka reported insider sales of Common Stock for CNR.
Rhea-AI Filing Summary
John Rothka reported insider sales of Common Stock for CNR. The filing shows a sale of $348,150 for 3,800 shares on 03/10/2026. The filing also lists 1,000 Common Shares tied to Restricted Stock Units dated 02/23/2026 under equity compensation.
Positive
- None.
Negative
- None.
Insights
Insider reported a routine restricted-share sale and lists RSUs.
The filing records a 3,800-share sale by John Rothka on 03/10/2026 for $348,150, a transaction size disclosed verbatim. It also lists 1,000 Common Shares linked to Restricted Stock Units dated 02/23/2026.
These items are routine compensation-related disclosures. Cash‑flow treatment and any planned resale mechanics are not detailed in the excerpt; subsequent filings would show method and timing if required.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the CNR filing disclose about insider John Rothka?
Does the filing state proceeds recipient or use of proceeds for the sale?
What do the listed Restricted Stock Units in the CNR filing indicate?
Which broker is shown on the filing for these transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.